Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV

NCT03310073 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

143

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: bOPV
BIOLOGICAL: Pentabio
BIOLOGICAL: IPV

Sponsor

PT Bio Farma